Logo for FT Big Read podcast

Purdue Pharma faces more than 1,000 lawsuits claiming it ignited and fuelled the US opioid crisis, reports David Crow. Prosecutors say the company exaggerated the benefits of its painkiller OxyContin, but through their ownership of Rhodes Pharma, Purdue’s owners also have a far bigger market share than was realised.

Get alerts on when a new story is published

Copyright The Financial Times Limited 2018. All rights reserved.

Comments have not been enabled for this podcast.

Follow the topics in this podcast